Showing results (51-60 of 1,497) with videos related to
Sort By:
Pageof 150
Current Oncology Reports|August 15, 2022
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision-a Literature ReviewDelphine Hudry, Stéphanie Bécourt, Giovanni Scambia, et al.Current Treatment Options in Oncology|January 8, 2016
Current Recommendations for Minimally Invasive Surgical Staging in Ovarian CancerAnna Fagotti, Federica Perelli, Luigi Pedone, et al.Journal of Minimally Invasive Gynecology|January 25, 2006
Laparoscopic diagnosis of asymptomatic megaureterAnna Fagotti, Francesco Fanfani, Maria Durante, et al.Journal of Minimally Invasive Gynecology|December 7, 2016
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case ReportFederico Romano, Francesco Legge, Giovanni Scambia, et al.Fitoterapia|May 25, 2015
Cyparissins A and B, jatrophane diterpenes from Euphorbia cyparissias as Pgp inhibitors and cytotoxic agents against ovarian cancer cell linesVirginia Lanzotti, Elisa Barile, Giovanni Scambia, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 25, 2025
Environment, lifestyle, and cancer in womenSara Farina, Alessandra Sabatelli, Stefania Boccia, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2025
New windows of surgical opportunity for gynecological cancers in the era of targeted therapiesInge Peters, Claudia Marchetti, Giovanni Scambia, et al.Cancers|October 2, 2019
PTEN and Gynecological CancersCamilla Nero, Francesca Ciccarone, Antonella Pietragalla, et al.Expert Opinion on Therapeutic Targets|June 18, 2009
Targeting CD133 antigen in cancerGabriella Ferrandina, Marco Petrillo, Giuseppina Bonanno, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2024
New windows of surgical opportunity for gynecological cancers in the era of targeted therapiesInge Peters, Claudia Marchetti, Giovanni Scambia, et al.Pageof 150